Hirak Der-Torossian Selected Research

Biomarkers (Surrogate Marker)

10/2021	Antitumor immune effects of preoperative sitravatinib and nivolumab in oral cavity cancer: SNOW window-of-opportunity study.
4/2015	Cancer cachexia update in head and neck cancer: Definitions and diagnostic features.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hirak Der-Torossian Research Topics

Disease

11	Neoplasms (Cancer) 02/2024 - 12/2012
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2023 - 01/2022
4	Cachexia 07/2015 - 12/2012
3	Colorectal Neoplasms (Colorectal Cancer) 04/2024 - 01/2023
3	Diarrhea 02/2024 - 01/2022
3	Nausea 02/2024 - 01/2022
2	Fatigue 02/2024 - 01/2022
2	Carcinoma (Carcinomatosis) 12/2023 - 10/2021
2	Renal Cell Carcinoma (Grawitz Tumor) 10/2023 - 01/2022
1	Urinary Bladder Neoplasms (Bladder Cancer) 12/2023
1	Neoplasm Metastasis (Metastasis) 10/2023
1	Biliary Tract Neoplasms (Biliary Tract Cancer) 01/2023
1	Vomiting 01/2023
1	Squamous Cell Carcinoma of Head and Neck 10/2021
1	Hypertension (High Blood Pressure) 10/2021
1	Thrombocytopenia (Thrombopenia) 10/2021
1	Hypoxia (Hypoxemia) 10/2021
1	Head and Neck Neoplasms (Head and Neck Cancer) 07/2015
1	Atrophy 06/2013
1	Muscle Weakness 04/2013

Drug/Important Bio-Agent (IBA)

5	adagrasibIBA 04/2024 - 01/2022
4	glesatinibIBA 02/2024 - 01/2022
4	NivolumabIBA 12/2023 - 10/2021
4	sitravatinibIBA 12/2023 - 10/2021
3	Proteins (Proteins, Gene)FDA Link 01/2023 - 04/2013
2	Cetuximab (Erbitux)FDA Link 04/2024 - 01/2023
2	SuspensionsIBA 02/2024 - 01/2023
2	Alanine Transaminase (SGPT)IBA 02/2024 - 01/2023
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 02/2024 - 01/2023
2	TabletsIBA 02/2024 - 01/2023
2	Capsules (Microcapsules)IBA 02/2024 - 01/2023
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 03/2022 - 01/2022
2	Docetaxel (Taxotere)FDA Link 03/2022 - 01/2022
2	Biomarkers (Surrogate Marker)IBA 10/2021 - 04/2015
1	cyclopropapyrroloindoleIBA 12/2023
1	SaltsIBA 01/2023
1	glycolic acid (glycolate)IBA 01/2023
1	B7-H1 AntigenIBA 01/2022
1	PlatinumIBA 01/2022
1	RNA (Ribonucleic Acid)IBA 10/2021
1	Circulating Tumor DNAIBA 10/2021
1	Cell-Free Nucleic AcidsIBA 10/2021
1	Transcription Factors (Transcription Factor)IBA 06/2013
1	Phosphotransferases (Kinase)IBA 06/2013
1	NF-kappa B (NF-kB)IBA 06/2013
1	Myosins (Myosin)IBA 04/2013
1	Myosin Heavy Chains (Myosin Heavy Chain)IBA 04/2013

Therapy/Procedure

5	Therapeutics 12/2023 - 06/2013
1	Nephrectomy 10/2023
1	Drug Therapy (Chemotherapy) 01/2022
1	Drug Tapering 10/2021
1	Combined Modality Therapy 07/2015
1	Aftercare (After-Treatment) 04/2015
1	Caloric Restriction 12/2012